rewrite this title and make it good for SEODuPont partners with Uncountable on AI lab initiative By Investing.com

WILMINGTON, Del. – DuPont (NYSE:DD) announced today a collaboration with Uncountable to advance its AI-ready labs initiative across its research and development organization.

The partnership will focus on scaling digital lab workflows and expanding access to experimental data through Uncountable’s AI-driven platform for product and application development. The collaboration aims to standardize data collection and optimize R&D workflows across DuPont’s operations.

“High-quality, structured data is critical to achieving innovation excellence at scale—enabling advanced analytics, machine learning, and AI to accelerate delivery of solutions to our customers,” said Marty DeGroot, Chief Technology Officer at DuPont, according to a press release statement.

The platform will be used to design, test, and optimize formulations across DuPont’s business segments, which include healthcare, water, construction, and industrial markets. DuPont stated the collaboration is intended to increase R&D productivity and support its growth objectives.

Uncountable’s platform captures and structures data across the product development lifecycle. The company serves more than 150 customers across chemicals, advanced materials, consumer goods, food and agriculture, and pharmaceuticals sectors.

“By standardizing data and streamlining how experiments are captured and analyzed, we aim to help DuPont move faster from testing to insight—and accelerate delivery of new solutions to customers,” said Will Tashman, Co-Founder and Chief Customer Officer at Uncountable.

The collaboration represents DuPont’s continued investment in digital capabilities within its R&D operations. The company did not disclose financial terms of the partnership or provide specific timelines for implementation.

In other recent news, DuPont has completed the sale of its Aramids business to Arclin for approximately $1.8 billion. This transaction includes the Kevlar and Nomex brands and provides DuPont with pre-tax cash proceeds of about $1.2 billion, along with a $300 million note receivable and a non-controlling equity stake in Arclin valued at $325 million. Additionally, DuPont announced a quarterly dividend of $0.20 per share, payable on May 29, 2026, to shareholders of record as of May 15, 2026.

The company also plans to seek stockholder approval for a reverse stock split at a ratio between 1-for-2 and 1-for-4, with the decision to be made at the Annual Meeting of Stockholders on May 21, 2026. The exact ratio will be determined by the Board of Directors if the proposal is approved. These recent developments reflect DuPont’s strategic financial decisions and corporate actions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.